$VEEV

Veeva Systems (NYSE:VEEV) Price Target Cut to $220.00 by Analysts at Canaccord Genuity Group

Canaccord Genuity Group cut its Veeva Systems (NYSE:VEEV) price target to $220 from $235 and kept a “hold” rating, according to a Thursday research note cited by Benzinga. The target implies 23.27% upside. Veeva shares were $178.46 midday. The article also notes Q1 EPS of $2.24 vs $2.14 expected and revenue of $882.95M vs $857.73M.

Original reporting
Published Jun 4, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 4:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Veeva Systems (NYSE:VEEV) Price Target Cut to $220.00 by Analysts at Canaccord Genuity Group — source image
Decision brief

The 30-second read

$VEEVNeutralMed
01

Why it matters

This piece updates the sell-side stance via a specific price-target reduction (Canaccord) while reiterating that the company’s fundamentals were strong, creating a mixed setup for near-term trading.

02

Market read

A targeted analyst downgrade in price expectations arrives right after a beat-and-raise quarter, supporting range-bound trading unless additional estimate changes emerge.

03

What to watch

The article cites insider selling (director) and multiple target trims; traders may want to watch whether these are isolated or part of a broader estimate reset.

Relevance 8/10Novelty 6/10Timing: after-hours/next-session positioning following the research note and target cut

Background

Veeva recently reported quarterly results (June 3) with EPS and revenue above consensus and provided FY2027/Q2 2027 guidance.

Company-level read

Ticker impact

$VEEVNeutralMedium confidence
Context

Canaccord cut Veeva’s price target from $235 to $220 and kept a Hold rating, adding fresh sell-side pressure despite the recent earnings beat.

Expected impact

Choppy-to-soft bias near term; downside risk if more firms follow with lower targets or downgrades.

Evidence & confidence

The article’s incremental catalyst is the specific Canaccord target cut, while fundamentals cited (EPS/revenue beat and raised guidance) are supportive, offsetting directional clarity.

Market effects

Signals that life-sciences cloud/software names may be trading on valuation and execution expectations, not just quarterly beats.

Primarily US large-cap software sentiment; limited direct regional spillover beyond healthcare IT.

Low—research target revisions are company-specific and not tied to global macro or regulation.

Counterpoint

The earnings beat and guidance lift may outweigh target cuts; the stock could absorb downgrades if execution momentum persists.

Key entities

  • Veeva Systems

    Cloud software provider for life sciences; subject of the price-target cut and recent earnings/guidance details.

  • Canaccord Genuity Group

    Reduced Veeva’s target price to $220 and maintained a Hold rating.

Related articles

$VEEVMed

Veeva Acquires Copli; Launches Falcon MLR

Veeva Systems said it will acquire Copli ApS, a developer of agentic medical, legal and regulatory solutions for life sciences, for undisclosed consideration, expanding its AI capabilities. The company also launched Veeva Falcon MLR, available immediately, which it said could cut 70%+ of manual MLR labor within five years by automating compliance checks and reviews. Veeva shares were up 1.42% pre-market at $155.25.

$AVGOMed

S&P Futures Muted as Fresh U.S.-Iran Hostilities Lift Oil and Bond Yields, ADP Jobs Report and Broadcom Earnings on Tap

S&P 500 futures were muted as U.S. JOLTS job openings rose to 7.618M in April, above expectations, while oil and bond yields moved higher amid fresh U.S.-Iran tensions. Cleveland Fed President Beth Hammack said rates should stay unchanged for now. Investors awaited ADP jobs, ISM services, factory orders, and EIA crude inventories; 10-year Treasury yield was 4.49%.

$VEEVMedAI 9/10

Veeva (VEEV) Q1 2027 Earnings Call Transcript

Veeva reported fiscal Q1 2027 revenue of $883 million and non-GAAP operating income of $395 million, both above internal guidance, according to management. Professional services hit a record quarter, driven by R&D and consulting. Commercial subscription guidance rose $15 million for the year, including $10 million from the Ostro acquisition. Veeva also discussed early rollout of AI “Falcon” and ongoing Vault CRM migrations.